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Evaluation of medical tests presents challenges distinct
from those involved in the evaluation of therapies; in
particular, the very great importance of context and the
dearth of comprehensive RCTs aimed at comparing the
clinical outcomes of different tests and test strategies.
Available guidance provides some suggestions: 1) Use of
the PICOTS typology for clarifying the context relevant
to the review, and 2) use of an organizing framework for
classifying the types of medical test evaluation studies
and their relationship to potential key questions.
However, there is a diversity of recommendations for
reviewers of medical tests and a proliferation of con-
cepts, terms, and methods. As a contribution to the
field, this Methods Guide for Medical Test Reviews seeks
to provide practical guidance for achieving the goals of
clarity, consistency, tractability, and usefulness.
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ith the growing number, complexity, and cost of
medical tests, which tests can reliably be expected to
improve health outcomes, and under what circumstances? As
reflected in the increasing number of requests for systematic
reviews of medical tests under the Agency for Healthcare
Research and Quality (AHRQ) Evidence-based Practice
Center (EPC) Program, patients, clinicians, and policymakers
have a profound need for guidance on these questions.
Systematic reviews developed under the EPC Program
(sometimes labeled “evidence reports” or “technology assess-
ments”), are expected to be technically excellent and
practically useful. The challenge for EPC investigators is to
complete such reviews with limited time and resources—a
daunting prospect, particularly in the face of the near-
exponential growth in the number of published studies
related to medical tests (A MEDLINE® search using the
keyword “test.mp” demonstrates a doubling of the number of
citations approximately every 10 years since 1960). How can
EPC investigators respond to this challenge with reviews that
are timely, accessible, and practical, and that provide insight
into where there have been (or should be) advances in the
field of systematic review of medical tests?
This Methods Guide for Medical Test Reviews (referred to
hereafter as the Medical Test Methods Guide), produced by
researchers in AHRQ’s EPC Program, is intended to be a
practical guide for those who prepare and use systematic
reviews of medical tests; as such, it complements AHRQ’s
Methods Guide for Effectiveness and Comparative Effective-
ness Reviews
1 (hereafter referred to as the General Methods
Guide). Not only has the present Medical Test Methods Guide
been motivated by the increasing need for comprehensive
reviews of medical tests, it has also been created in recognition
of features of medical tests and the evaluation literature that
present unique problems for systematic reviewers. In particu-
lar, medical tests are used in—and are highly dependent on—a
complex context. This context includes preexisting conditions,
results of other tests, skill and knowledge of providers,
availability of therapeutic resources, and so on. In this
complex environment, researchers have tended to focus on
narrow questions, such as the ability of a test to conform to
technical specifications, to accurately classify patients into
diagnostic or prognostic categories, or to influence thought or
actions by clinicians and patients. Rarely are medical tests
evaluated in randomized controlled trials (RCTs) with repre-
sentative patient populations and comprehensive measures of
patient-relevant outcomes. As a result, the reviewer must put
together the evidence in puzzle-like fashion.
In addition to encouraging a high standard for excellence,
usefulness, and efficiency in systematic reviews, this Medical
Test Methods Guide is designed to promote consistency in
how specific issues are addressed across the various
systematic reviews produced by investigators. Even though
consistency in approach may not always guarantee that a
particular task in review development is done in an ideal
way, it is certainly the case that inconsistency in approach
increases the effort and energy needed to read, digest, and
apply the results of systematic reviews of medical tests.
DEVELOPMENT OF THE MEDICAL TEST METHODS
GUIDE
In developing this Medical Test Methods Guide, we sought to
apply theory and empirical evidence, supplemented by personal
S4experience and judgment, and to maintain consistency as much
as possible with the principles described in AHRQ’s General
Methods Guide. We were guided by two fundamental tenets: 1)
Evaluation of the value of a medical test must always be linked
to the context of use; and 2) systematic reviews of medical test
studies are ultimately aimed at informing the use of those tests
to improve the health outcomes of patients, in part by guiding
clinicians to make rational decisions and judgments.
The first tenet stands in contradiction to the common
assumption that medical test results are neutral reporters of
reality, independent of context. The notion that tests are
“signal detectors” with invariant performance characteristics
(i.e., sensitivity and specificity), likely reflects the way that the
Bayes rule has been introduced to the medical community—
as a pedagogical tool for transmitting the insight that a test for
a condition must be interpreted in light of the likelihood of the
condition before the test is performed (prior probability). Such
teaching assumes that the performance characteristics of a
medical test (like those of electronic receivers and similar
devices) are constant over all relevant situations. There are
clearly circumstances where this is true enough for practical
purposes. However, the possibility that it may not be true
across all relevant applications highlights the importance of
context, which can affect not only sensitivity and specificity
but also the clinical implications of a particular test result.
Thus, throughout this document the authors return to the
theme of clarifying the context in which the test under
evaluation is to be used.
The second tenet is that medical tests (and therefore assess-
ments of those tests) are about improving patient outcomes,
often by guiding clinicians’ judgments. Unfortunately, the vast
majority of published literature on medical tests does not
address the clinical impact of tests, focusing instead on test
development and test performance characteristics. Indeed, test
performance characteristics have been treated as the sine qua
non of test value (i.e., if the performance characteristics are
good, then the test should be promoted). For example, a test
with sensitivity and specificity in the high 90-percent range
may not improve the likelihood of a good patient outcome if
the underlying condition prevalence or risk is low, or if the
treatment options are of marginal efficacy or high risk. This
Medical Test Methods Guide promotes the centrality of patient
outcomes by recommending that one of the first steps in a
review must be to establish a link between the use of a test and
the outcomes patients and clinicians care about. This link can
also be expounded through the use of visual representations
such as the causal chain diagram, illustrated in a simplified
form in Figure 1.
In rare but ideal cases, a test is evaluated in a comprehensive
clinical trial in which every relevant outcome is assessed in a
representative group of patients in typical practice settings.
More often, however, a systematic review may appropriately
focus on only one link in this chain, as when the test is being
compared with an established test known to improve out-
comes. Ideally, the entire chain should be considered and
evidence regarding each link assembled, evaluated, and
synthesized.
UNIQUE CHALLENGES OF MEDICAL TESTS
Of the many tools available to clinicians caring for patients,
medical tests [note that here the term “medical tests” is used as
an umbrella to denote any test used in a health care context,
irrespective of type (e.g., chemistry, genetic, radiological) or
role (e.g., screening, diagnosis, or prognosis)] are among the
most commonly employed. Tests can be used to screen for the
likelihood of a disorder currently or in the future, or to
diagnose the actual presence of disease. Medical tests may
also be used to assess immediate or future response to
treatment, including the probability of desirable or undesirable
consequences. While medical tests are often thought of as
something performed in the laboratory or radiology suite, such
tests also encompass the traditional patient history and
physical examination, as well as scored questionnaires
intended, for example, for screening or to assess likely
prognosis or response to therapy.
Assessing the impact of a treatment is generally more
straightforward than assessing the impact of a medical test.
This is primarily because most treatments lead directly to the
intended result (or to adverse effects), whereas tests may have
several steps between the performance of the test and the
outcome of clinical importance.
2 One consequence is that
medical tests tend to be evaluated in isolation, in terms of their
ability to discern an analyte or a particular anatomic condition,
rather than in terms of their impact on overall health
outcomes.
3
In light of these challenges, the question we address
directly in this Medical Test Guide is, How do we evaluate
medical tests in a way that is clear (involves a process that
can be reproduced), consistent (is similar across reports),
tractable (can be performed within resource constraints),
and useful (addresses the information needs of the report
recipients)?
To answer this question, we might refer to the literature
on evaluation of therapies. Arguably, the most robust
empirical demonstration of the utility of a medical test is
through a properly designed randomized controlled trial
4–7
that compares patient management outcomes of the test to
the outcomes of one or more alternative strategies. In
practice, such trials are not routinely performed because
they are often deemed unattainable.
Decision
Categorization 
(e.g., high risk, 
disease present)
Result Test Patient 
Outcome
Figure 1
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Causal chain diagram. .RECURRENT THEMES IN THE TEST EVALUATION
LITERATURE
In recognition of the unique challenges to evaluation
presented by medical tests, a body of test evaluation
literature has emerged over the past six decades.
8 Two
recurrent themes emerge from this literature. The first is the
recognition that a medical test used to discriminate between
the presence or absence of a specific clinical condition can
be likened to an electronic signal detector.
9–11 This has
opened the way to applying signal detection theory,
including the notions of sensitivity, specificity, and the
application of Bayes rule, to calculate disease probabilities
for positive or negative test results.
9–11
The second theme reflected in the historical record is that
medical test evaluation studies tend to fall along a
continuum related to the breadth of the study objectives—
from assessing a test’s ability to conform to technical
specifications, to the test’s ability to accurately classify
patients into disease states or prognostic levels, to the
impact of the test on thought, action, or outcome. Various
frameworks have been developed to describe the different
outcomes of the study. Table 1 below consolidates these
terms, with relevant examples, into four basic categories.
Further descriptions of the various frameworks are included
in the following sections.
ANALYTIC FRAMEWORKS
While the preceding provides a way to classify test
evaluation studies according to their objective, it does not
offer the reviewer an explicit strategy for summarizing an
often complex literature in a logical way in order to respond
to key questions. In 1988, Battista and Fletcher applied
“causal pathways” for the United States Preventive Services
Task Force (USPSTF) in the study of evaluating preventive
services, as a test for understanding and evaluating the
strength of support for the use of a preventive measure.
12
Such a framework is useful in maintaining an orderly
process, clarifying questions, and organizing evidence into
relevant categories. This value has been reiterated in other
recommendations for reviewers.
13–15 In 1991, Woolf de-
scribed a conceptual model that he termed the “Evidence
Model,”
16 and in 1994, he described this same model as the
“analytic framework.”
17
These points were reiterated in the most recent Procedure
Manual for the USPSTF:
The purpose of analytic frameworks is to present
clearly in graphical format the specific questions that
need to be answered by the literature review in order
to convince the USPSTF that the proposed preventive
service is effective and safe (as measured by out-
comes that the USPSTF considers important). The
specific questions are depicted graphically by linkages
that relate interventions and outcomes. These linkages
serve the dual purpose of identifying questions to help
structure the literature review and of providing an
“evidence map” after the review for the purpose of
identifying gaps and weaknesses in the evidence.
18
Two key components of the analytic framework are 1) a
typology for describing the context in which the test is to be
used, and 2) some form of visual representation of the
relationship between the application of the test or treatment
and the outcomes of importance to decisionmaking. Visual
display of essential information for defining key questions
will also explicitly define the population, intervention,
Table 1. Different Objectives of Medical Test Evaluation Studies
Study objective Terms used Examples
Ability of a test to 
conform to technical 
specifications
Technical efficacy Technical quality of a radiological 
image
Analytic validity Accuracy of a chemical assay for the 
target analyte
Concordance of a commercial 
genetic test with the true genotype 
Ability of a test to 










Positive and negative likelihood 
ratios
Positive and negative predictive 
value
Test yield
Receiver operating characteristic 
(ROC) curve
Ability of test to direct 
clinical management 




Patient outcome efficacy 
Clinical utility 
Impact on mortality or morbidity
Impact on clinician judgment about 
diagnosis/prognosis
Impact on choice of managment
Ability of the test to 
benefit society as a 
whole
Societal efficacy Incremental cost-effectiveness
S6 Matchar: The Methods Guide for Medical Test Reviews JGIMcomparator and outcomes, which makes analytic frameworks
consistent with the current standard approach to classifying
contexts, the PICOTS typology, which is further described
below (and for more on the PICOTS typology, see Paper 2.)
In addition to using the analytic framework in reviews to
support clinical practice guidelines and the USPSTF, the
AHRQ EPC Program has promoted the use of analytic
frameworks in systematic reviews of effectiveness or compar-
ative effectiveness of non-test interventions.
1 Although not
specifically recommending a visual representation of the
framework, the Cochrane Collaboration also organizes key
questions using a similar framework.
19
A NOTE ON TERMINOLOGY
With the evolution of the field, there has been a proliferation
of terms used to describe identical or similar concepts in
medical test evaluation. In this Medical Test Methods Guide,
we have attempted to identify similar terms and to be
consistent in our use of terminology. For example, through-
out this document, we use terms for different categories of
outcomes (Table 1) that are rooted in various conceptual
frameworks for test evaluation (hereafter referred to as
“organizing frameworks,” although elsewhere referred to as
“evaluative” or “evaluation” frameworks). There have been
many different organizing frameworks; these have recently
been systematically reviewed by Lijmer and colleagues.
5
Each framework uses slightly different terminology, yet each
maps to similar concepts.
To illustrate this point, Figure 2 shows the relationship
between three representative organizing frameworks: 1) The
“ACCE” model of Analytic validity, Clinical validity,
Clinical utility, and Ethical, legal and social implications,
20,21
2) the Fryback and Thornbury model, one of the most widely
used and well-known of all the proposed organizing frame-
works,
22 and 3) the USPSTF model for assessing screening
and counseling interventions.
23 Since the key concepts are
similar, unless another framework is especially apt for a
particular review task, our principle of achieving consistency
would argue for use of the USPSTF (see Paper 2).
PICOTS TYPOLOGY
A formalism that has proven extremely useful for the
evaluation of therapies, and which also applies to the
evaluation of medical tests, is the PICOTS typology. The
PICOTS typology—Patient population, Intervention, Com-
parator, Outcomes, Timing, Setting—is a tool established
Figure
8 b a s e do nt h e
specified evaluation frameworks. For a detailed description of each included framework, the reader is referred to the original references.
16–19
Domain 1—analytical validity; Domain 2—clinical validity; Domain 3—clinical utility; Domain 4—ethical, legal and societal implications.
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2.  A mapping across three major organizing frameworks for evaluating clinical tests. Notes: ECRI Institute created this figureby systematic reviewers to describe the context in which
medical interventions might be used and is thus important
for defining the key questions of a review and assessing
whether a given study is applicable or not.
24
The EPC Program, reflecting the systematic review
community as a whole, occasionally uses variations of the
PICOTS typology (Table 2). The standard, unchanging
elements are the PICO, referring to the Patient population,
Intervention, Comparator, and Outcomes. Timing refers to
the Timing of outcome assessment and thus may be
incorporated as part of Outcomes or as part of Intervention.
Setting may be incorporated as part of Population or
Intervention, but it is often specified separately because it
is easy to describe. For medical tests, the setting of the test
has particular implications on bias and applicability in light
of the spectrum effect. Occasionally, “S” may be used to
refer to Study design. Other variations, not used in the
present document, include a “D” that may refer to Duration
(which is equivalent to Timing) or to study Design.
ORGANIZATION OF THIS MEDICAL TEST METHODS
GUIDE
As noted above, this Medical Test Methods Guide comple-
ments AHRQ’s General Methods Guide,
1 which focuses on
methods to assess the effectiveness of treatments and other
non-test interventions. The present document applies the
principles used in the General Methods Guide to the specific
issues and challenges of assessing medical tests and high-
lights particular areas where the inherently different qualities
of medical tests necessitate a variation of the approach used
for a systematic review of treatments. We provide guidance
in stepwise fashion for those conducting a systematic review.
Papers 2 and 3 consider the tasks of developing the topic,
structuring the review, developing the key questions, and
defining the range of decision-relevant effects. Developing the
topic and structuring the review—often termed “scoping”—
are fundamental to the success of a report that assesses a
medical test. Success in this context means not only that the
report is deemed by the sponsor to be responsive but also that
it is actually used to promote better quality care. In this
Medical Test Methods Guide, we introduce various frame-
works to help determine and organize the questions. While
there is not a specific section on developing inclusion and
exclusion criteria for studies, many of the considerations at
this stage are highlighted in Papers 2 and 3, which describe
how to determine the key questions, as well as in Papers 5 and
6, which describe how to assess the quality and applicability
of studies.
Papers 4 through 10 highlight specific issues in conducting
reviews: searching, assessing quality and applicability,
grading the body of evidence, and synthesizing the evidence.
Searching for medical test studies (Paper 4) requires unique
strategies, which are discussed briefly. Assessing individual
study quality (Paper 5) relates primarily to the degree to
which the study is internally valid; that is, whether it
measures what it purports to measure in as unbiased a
fashion as possible. Although much effort has been expended
to rate features of studies in a way that accurately predicts
which studies are more likely to reflect “the truth,” this goal
has proven elusive. In Paper 5, we note several approaches to
assessing the limitations of a study of a medical test and
recommend an approach.
Assessing applicability (Paper 6) refers to determining
whether the evidence identified is relevant to the clinical
context of interest. Here we suggest that systematic reviewers
search the literature to assess which factors are likely to affect
test effectiveness. We also suggest that reviewers comple-
ment this with a discussion with stakeholders to determine
which features of a study are crucial (i.e., which must be
abstracted, when possible, to determine whether the evidence
Table 2. The PICOTS Typology as Applied to Interventions and Medical Tests
Element As applied to
interventions
As applied to medical tests Comment
P Patient population Patient population; includes results
of other/prior tests
Condition(s), disease severity and stage,
comorbidities, patient demographics
I Intervention Index test; includes clinical role
of index strategy in relation to
comparator, and
test-and-treat strategy
in relation to clinical outcomes
Description of index test; includes administrator training,
technology specifications, specific application issues
Three main clinical roles in relation to comparator:
replacement, add-on, triage
Desciption of index test performance and interpretation;
how results of index test lead to management decisions/actions
C Comparator Comparator test-and-treat strategy Desciption of comparator test performance and interpretation;
how results of comparator test lead to management decisions/
actions
O Outcomes Relevant clinical outcomes; includes
any intermediate outcomes of
interest
Patient health outcomes; includes morbidity (including adverse
effects of test and treatment), mortality, quality of life;
intermediate outcomes includes technical
specifications, accuracy, decisional, therapeutic impact
T Timing Timing of outcome assessment Duration of follow-up; single or multiple follow-up assessments
S Setting Setting of test assessment Ambulatory settings (including primary, specialty care)
and inpatient settings
S8 Matchar: The Methods Guide for Medical Test Reviews JGIMis relevant to a particular key question, or whether the results
are applicable to a particular subgroup.) Once systematic
reviewers identify and abstract the relevant literature, they
may grade the body of literature as a whole (Paper 7). One
way to conceptualize this task is to consider whether the
literature is sufficient to answer the key questions such that
additional studies might not be necessary or would serve
only to clarify details of the test’s performance or utility. In
Paper 7, we discuss the challenges and applications of
grading the strength of a body of test evidence.
Papers 8 through 10 focus on the technical approach to
synthesizing evidence, in particular, meta-analysis and
decision modeling. Common challenges addressed include
evaluating evidence when a reference standard is available
(Paper 8) and when no appropriate reference standard exists
(Paper 9). In reviewing the application of modeling in
clinical test evidence reviews, we focus in Paper 10 on
evaluating the circumstances under which a formal model-
ing exercise may be a particularly useful component of an
evidence review.
Finally, in Papers 11 and 12, we consider special issues
related to the evaluation of genetic tests and prognostic
tests, respectively. While both topics are represented in
earlier papers, those papers focus on methods for evaluating
tests to determine the current presence of disease, as with
screening or diagnostic tests. Papers 11 and 12 complete the
guidance by addressing special considerations of assessing
genetic and prognostic tests.
SUMMARY
Evaluation of medical tests presents challenges distinct
from those involved in the evaluation of therapies; in
particular, the very great importance of context and the
dearth of comprehensive RCTs aimed at comparing the
clinical outcomes of different tests and test strategies.
Available guidance provides some suggestions: 1) Use of
the PICOTS typology for clarifying the context relevant to
the review, and 2) use of an organizing framework for
classifying the types of medical test evaluation studies and
their relationship to potential key questions. However, there
is a diversity of recommendations for reviewers of medical
tests and a proliferation of concepts, terms, and methods. As
a contribution to the field, this Medical Test Methods Guide
seeks to provide practical guidance for achieving the goals
of clarity, consistency, tractability, and usefulness.
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